Opendata, web and dolomites

BioAhead SIGNED

BioAhead – an innovative optimization algorithm for amino acid chain analytics

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 BioAhead project word cloud

Explore the words cloud of the BioAhead project. It provides you a very rough idea of what is the project "BioAhead" about.

faster    optimize    globosoft    drug    society    model    bioahead    medicines   

Project "BioAhead" data sheet

The following table provides information about the project.

Coordinator
GLOBOSOFT GMBH 

Organization address
address: AM STEINACHER UFER KREUZ 22
city: NURNBERG
postcode: 90427
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Germany [DE]
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.2.1.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Information and Communication Technologies (ICT))
2. H2020-EU.2.3.1. (Mainstreaming SME support, especially through a dedicated instrument)
 Code Call H2020-SMEINST-1-2016-2017
 Funding Scheme /SME-1
 Starting year 2017
 Duration (year-month-day) from 2017-12-01   to  2018-05-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    GLOBOSOFT GMBH DE (NURNBERG) coordinator 50˙000.00

Mappa

 Project objective

Globosoft GmbH aims to optimize the drug development process of drug manufacturers, enabling faster and more efficient development of drugs in Europe and worldwide. For this purpose, Globosoft GmbH has developed the innovative optimization algorithm called BioAhead to optimize acid chain analysis, as part of the protein structure modeling field. The innovation will create growth in terms of income and new job creation and have a high return on investment. The proposed model has a high potential for a fast up-take by the market, considering the savings in time and money and also a cloud technology that will make the model easy-to-use in any country. BioAhead adequately addresses issues related to the society. With faster and more accurate drug development processes, the society in Europe and world-wide can benefit from low- priced medicines, faster drug development and highly specialized medicines, which are currently too expensive for economic development.

 Work performed, outcomes and results:  advancements report(s) 

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "BIOAHEAD" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "BIOAHEAD" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.2.1.1.;H2020-EU.2.3.1.)

BioAhead (2017)

BioAhead – an innovative optimization algorithm for amino acid chain analytics

Read More  

Piql-GO (2018)

Ultra-secure data storage - and long-term preservation of digital and analogue data

Read More  

LymphoDrain (2017)

First subcutaneous implant to treat lymphedema. Definitive solution for chronic lymphedema

Read More